- Home
- ALGS vs CDLX Comparison
ALGS vs CDLX Comparison
Compare ALGS & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALGS | CDLX |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.2M | 69.7M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ALGS | CDLX |
|---|---|---|
| Price | $8.19 | $1.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $46.67 | $2.25 |
| AVG Volume (30 Days) | 79.7K | ★ 813.1K |
| Earning Date | 03-09-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,646,000.00 | ★ $251,175,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.76 | $0.85 |
| 52 Week High | $30.02 | $4.03 |
Technical Indicators
Market Signals| Indicator | ALGS | CDLX |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 37.68 |
| Support Level | $7.92 | $1.07 |
| Resistance Level | $9.13 | $1.26 |
| Average True Range (ATR) | 0.91 | 0.11 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 15.97 | 5.88 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.